Skip to main content

Table 2 Efficacy evaluation of AL(artemether lumefantrine), ASAQ (artesunate amodiaquine) and DHAP (dihydroartemisinin) in the treatment of P. falciparum malaria in Cameroon children

From: Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children

 

ITT

PP

Efficacy evaluation

No PCR correction

n

%

95% CI

N

%

95% CI

AL

138

80.4

72.6-86.4

123

91

84.2-95.2

ASAQ

279

81.4

76.1-85.7

255

89.4

84.8-92.7

DHAP

280

80.4

75.1-85.7

245

89.4

84.6-92.8

PCR corrected

AL

138

92

85.9-95.7

123

96.7

91.3-98.9

ASAQ

279

91

89.3-95.7

255

98.1

95.2-99.2

DHAP

280

89

85.3-92.8

245

96.3

92.9-98.2

  1. ITT = intention to treat population; PP = per protocol population.